These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9138122)

  • 1. Drug-induced cholestasis.
    Erlinger S
    J Hepatol; 1997; 26 Suppl 1():1-4. PubMed ID: 9138122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-induced cholestasis.
    Larrey D; Erlinger S
    Baillieres Clin Gastroenterol; 1988 Apr; 2(2):423-52. PubMed ID: 3044469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Secondary drug-induced cholestasis with bile duct involvement].
    Horsmans Y; Harvengt C
    Acta Gastroenterol Belg; 1991; 54(1):27-33. PubMed ID: 2058347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer.
    Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G
    Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keratin 7 expression in hepatic cholestatic diseases.
    Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
    Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases.
    Trauner M; Fickert P; Halilbasic E; Moustafa T
    Wien Med Wochenschr; 2008; 158(19-20):542-8. PubMed ID: 18998069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced bile duct injury.
    Visentin M; Lenggenhager D; Gai Z; Kullak-Ublick GA
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1498-1506. PubMed ID: 28882625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced cholestasis.
    Zimmerman HJ; Lewis JH
    Med Toxicol; 1987; 2(2):112-60. PubMed ID: 3553833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular regulation of hepatobiliary transport systems: clinical implications for understanding and treating cholestasis.
    Trauner M; Wagner M; Fickert P; Zollner G
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S111-24. PubMed ID: 15758646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced cholestasis.
    Velayudham LS; Farrell GC
    Expert Opin Drug Saf; 2003 May; 2(3):287-304. PubMed ID: 12904107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular transporters and cholestasis.
    Pauli-Magnus C; Meier PJ
    J Clin Gastroenterol; 2005 Apr; 39(4 Suppl 2):S103-10. PubMed ID: 15758645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of cholestasis.
    Desmet VJ
    Verh Dtsch Ges Pathol; 1995; 79():233-40. PubMed ID: 8600686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology and Diseases of the Proximal Pathways of the Biliary System.
    Nakanishi Y; Saxena R
    Arch Pathol Lab Med; 2015 Jul; 139(7):858-66. PubMed ID: 26125426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of cholestasis. 6. Bile acids in human livers with or without biliary obstruction.
    Greim H; Trülzsch D; Czygan P; Rudick J; Hutterer F; Schaffner F; Popper H
    Gastroenterology; 1972 Nov; 63(5):846-50. PubMed ID: 5079493
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders.
    Vleggaar FP; Van Ooteghem NA; Van Buuren HR; Van Berge Henegouwen GP
    Scand J Gastroenterol Suppl; 2000; (232):86-92. PubMed ID: 11232499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment.
    Stiehl A; Rudolph G; Sauer P; Theilmann L
    J Hepatol; 1995 Sep; 23(3):283-9. PubMed ID: 8550992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histoautoradiographic localization of taurocholate in rat liver after bile duct ligation. Evidence for ongoing secretion and reabsorption processes.
    Buscher HP; Miltenberger C; MacNelly S; Gerok W
    J Hepatol; 1989 Mar; 8(2):181-91. PubMed ID: 2715621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new xenobiotic-induced mouse model of sclerosing cholangitis and biliary fibrosis.
    Fickert P; Stöger U; Fuchsbichler A; Moustafa T; Marschall HU; Weiglein AH; Tsybrovskyy O; Jaeschke H; Zatloukal K; Denk H; Trauner M
    Am J Pathol; 2007 Aug; 171(2):525-36. PubMed ID: 17600122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Importance of liver puncture biopsy and endoscopic retrograde cholangiography in patients with chronic anicteric unexplained cholestasis. A retrospective study in 79 patients].
    Sapey T; Turlin B; Canva-Delcambre V; Mendler MH; Deugnier Y; Brissot P; Guyader D
    Gastroenterol Clin Biol; 1999 Feb; 23(2):178-85. PubMed ID: 10353011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of bcl-2 in ductular proliferation is related to periportal hepatic stellate cell activation and fibrosis progression in patients with autoimmune cholestasis.
    Sánchez-Muñoz D; Castellano-Megías VM; Romero-Gómez M
    Dig Liver Dis; 2007 Mar; 39(3):262-6. PubMed ID: 17270507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.